Antimalarial drugs are key tools for the control and elimination of malaria. Recent decreases
in the global malaria burden are likely due, in part, to the deployment of artemisinin-based …

Background Homogeneity and consistency assumptions underlie network meta‐analysis
(NMA). Methods exist to assess the assumptions but they are rarely and poorly applied. We …

Background Intermittent treatment with sulfadoxine–pyrimethamine, recommended for
prevention of malaria in pregnant women throughout sub-Saharan Africa, is threatened by …

Introduction Substandard and falsified medications pose significant risks to global health.
Nearly one in five antimalarials circulating in low-and middle-income countries are …

Controlling the spread of antimalarial drug resistance, especially resistance of P lasmodium
falciparum to artemisinin‐based combination therapies, is a high priority. Available data …

Background Artemether–lumefantrine and artesunate–amodiaquine are used as first-line
artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate …

Background Gametocytes are responsible for transmission of malaria from human to
mosquito. Artemisinin combination therapy (ACT) reduces post-treatment gametocyte …

Background: Information regarding the safety and efficacy of artemisinin combination
treatments for malaria in pregnant women is limited, particularly among women who live in …

Background. Artemisinin-based combination therapy (ACT) reduces the potential for malaria
transmission, compared with non-ACTs. It is unclear whether this effect differs between …

Reduced susceptibility of Plasmodium falciparum toward artemisinin derivatives has been
reported from the Thai-Cambodian and Thai-Myanmar borders. Following increasing reports …